MacroGenics | Kostnadene For Salg

Cost Of Sales Endring Dato
AbbVie USD 4.28B 90M 2023-12
Amgen USD 3.11B 1.31B 2023-12
AstraZeneca USD 2.06B 91M 2023-09
Eli Lilly USD 1.79B 72.1M 2023-12
Gilead Sciences USD 1.61B 46M 2023-12
Pfizer USD 6.66B 2.24B 2023-12
Regeneron Pharmaceuticals USD 517M 80.6M 2023-12
Roche Holding CHF 7.62B 1.33B 2023-06



MacroGenics Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.